MedTrace Logo

Peanuts for Cardiometabolic, Brain, and Intestinal Health

NCT06867198 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-03-27

No results posted yet for this study

Summary

The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.

Conditions

  • Prediabetes
  • Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
  • Cognition
  • Microvascular Function
  • Gut Microbiota
  • Endothelial Function (Reactive Hyperemia)
  • Arterial Stiffness, Blood Pressure
  • Adult

Interventions

DIETARY_SUPPLEMENT

Peanuts

43 g of peanut butter (1 snack cup) 3 x/week, 42 g of dry roasted peanuts (1/3 of a cup) 3x/week, or 56 g of peanut flour 1x/week for 6 months.

Sponsors & Collaborators

  • United States Department of Agriculture (USDA)

    collaborator FED

  • The Peanut Institute

    collaborator OTHER

  • Georgia State University

    lead OTHER

Principal Investigators

  • Rafaela G Feresin, PhD · Georgia State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-06
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06867198 on ClinicalTrials.gov